Latest / Dayton News Today | 2 Min News | The Daily News Now!
GLP-1 Drugs for Teens and Medicare Access | Dayton News
GLP-1 drugs like Wegovy, already a breakthrough for adult obesity, are now FDA-approved for teens 12 and older with severe obesity and related health risks—after diet and exercise fail. Doctors see early intervention as key to preventing lifelong complications, though questions linger about long-term use, side effects, and whether meds might replace healthy habits. Meanwhile, Medicare’s new $50 monthly GLP-1 Bridge Program offers temporary access to eligible patients, but strict eligibility and high costs still limit widespread use. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.